We previously demonstrated oxidative stress in euthymic patients with bipolar I and II disorder. 1 We revealed that, compared to healthy controls, bipolar patients had reduced total glutathione in peripheral blood and increased levels of oxidation. We also unexpectedly found a relationship between age of onset of illness and increased oxidative stress. Our data suggested that people with a later onset had higher levels of oxidative stress, as determined by measuring glutathione.
| INTRODUC TI ON
We previously demonstrated oxidative stress in euthymic patients with bipolar I and II disorder. 1 We revealed that, compared to healthy controls, bipolar patients had reduced total glutathione in peripheral blood and increased levels of oxidation. We also unexpectedly found a relationship between age of onset of illness and increased oxidative stress. Our data suggested that people with a later onset had higher levels of oxidative stress, as determined by measuring glutathione.
We had expected that the reverse might be more likely, and that length of illness might then, more plausibly, determine levels of oxidative stress. Our opposite finding suggested that oxidative stress might instead be a risk factor for later onset of bipolar disorder.
In this study, we wanted to replicate our original finding in a different cohort of patients, and with a more accurate method of determining glutathione and its plasma redox state. Our previous method was the glutathione recycling assay, 2 which cannot differentiate between sulfhydryls of cysteines, glutathione, and other small DOI: 10.1111/bdi.12640
O R I G I N A L A R T I C L E
Plasma glutathione suggests oxidative stress is equally present in early-and late-onset bipolar disorder ease. 6, 7 More recently, studies have shown that in unipolar depression the amount of mitochondrial DNA (mtDNA) increases with stress. 8 As there is an intimate link between mitochondria and oxidative stress 9, 10 and some studies have shown alterations in mtDNA but without any oxidative stress measure, 11, 12 we also compared mtDNA copy number between bipolar patients and control subjects.
For this study, we recruited a new cohort of bipolar I and II patients, and divided them prospectively according to age of disease onset. We hypothesized that we would again see an increase in plasma glutathione redox state, indicative of oxidative stress, in bipolar patients compared to healthy controls, and we would confirm that the highest levels of oxidative stress occurred in late-onset bipolar patients as we had observed before.
| ME THODS

| Ethics
The study was approved by the National Research Ethics Committee South Central-Oxford A (Ref 10/H0604/13) and was in accordance with the Helsinki Declaration of 1975. All participants provided written informed consent before entering the study.
| Participants
Bipolar patients who fulfilled the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV) 13 who had a mean (±SD) age of onset of illness 38.8 (±7.5) years.
There was no overlap between the two groups. Self-reported mood scores and sociodemographic and clinical data were collected from the patients as described previously. 1 Age-and body mass index (BMI)-matched healthy controls (N = 29) were also recruited within the same geographical area using print and online posters. Control participants were also administered the SCID to rule out any history of axis I psychiatric disorders. Exclusion criteria for all groups included pregnancy and/or lactation.
| Blood collection and processing
Blood was collected in two 5-mL BD vacutainers lined with ethylenediaminetetra-acetic acid (EDTA) (# 367525; BD, Franklin Lakes, NJ, USA) at 12 pm ± 1 hour to minimize circadian variations.
One tube of whole blood was frozen immediately and used at a later date to carry out mitochondrial DNA quantification. The sample processing for glutathione (reduced plus oxidized), cysteine and cystine levels was carried out as described in Jones et al. 3, 15 Briefly, from the second tube, a specified volume of blood was withdrawn within 2 min of collection and added to an Eppendorf tube (A) containing a "preservation solution" 15 and centrifuged at 9800 g at room temperature for 30 seconds to separate the plasma. If there were any signs of haemolysis, the sample was discarded. The plasma supernatant was removed and placed in a separate Eppendorf tube (B) containing an internal standard (γ-glutamylglutamate) in an acid solution. The "B" tubes were stored at −80°C until they were shipped to Emory University, Atlanta, GA, USA where they were analysed in the laboratory of Professor Dean Jones using an HPLC method. 3, 15 Extraction and quantification of mtDNA were carried out as described in Cai et al. 8 using a quantitative polymerase chain reaction (qPCR)-based assay. All experimental analyses were carried out under blinded conditions by someone who did not know the group designations.
| Statistical analysis
Statistical analyses were performed with Graphpad prism 6 (GraphPad, La Jolla, CA, USA). Data were tested for normality with the D'Agostino and Pearson omnibus normality test to determine the appropriate subsequent statistical test. Outliers were determined using Rout's test and excluded. Determination of statistical significance was carried out using a one-way analysis of variance (ANOVA) with the Holm-Sidak correction for multiple comparisons.
All P-values have been corrected for multiple comparisons. In some cases, as deemed appropriate, two-tailed unpaired t tests have been used to determine statistical significance.
Pearson's and Spearman's product-moment correlations were conducted to determine relationships between variables for normally distributed and non-normally distributed data, respectively.
| RE SULTS
| Demographics
The participants' demographic and clinical characteristics are summarized in Table 1 . There were no significant differences in age and BMI measures between the three groups.
| Glutathione
A significant increase was observed in oxidized glutathione levels ( Figure 1B ) between controls and both patient groups (P = .0012
and .035 for controls vs early-onset patients, and controls vs lateonset patients, respectively). No significant difference in oxidized glutathione was observed between the early-and late-onset patient groups. Additionally, no significant differences between the three groups were observed in the reduced form ( Figure 1A ) or in total plasma glutathione ( Figure 1E ).
The structure shown in Figure 1C is a reduced glutathione molecule. On oxidation, two such molecules form a disulphide bond to create one molecule of oxidized glutathione (structure show in Figure 1D ).
None of the measured biochemical parameters differed between the early-onset and late-onset bipolar patient groups ( Figures 1A, B, E, F).
| Glutathione redox state
A precise measure of the oxidative state of a physiological system, which considers both reducing and oxidizing components, is the redox potential. It can be calculated from the Nernst equation using the measured absolute reduced and oxidized glutathione values. 15, 16 Based on this redox potential, there were no difference between the early-and late-onset patients ( Figure 1F ; mean ± SD;
−117.7 ± 7.2 mV vs −118.4 ± 8.6 mV, respectively). However, as a single group, bipolar patients had an overall more positive (or oxidizing) redox state, compared to healthy controls (mean ± SD, −118.0 ± 7.8 mV vs −123.8 mV ± 7.1 mV, respectively; P = .002 using an unpaired t test).
| Glutathione correlations with age of onset
No significant correlations were observed between the age of onset of bipolar disorder and reduced glutathione (Figure 2A ), oxidized glutathione ( Figure 2B ), total glutathione ( Figure 2C ) and glutathione redox state ( Figure 2D ).
| Cysteine and cystine
We found no differences in cysteine (Cys) ( Figure 3A ), cystine (Cyss) ( Figure 3B ), total cysteine+cystine ( Figure 3E ) and cysteine-cystine redox state ( Figure 3F ). As in the case of glutathione, two cysteine molecules (structure shown in Figure 3C ) are oxidized and bond via a disulfide to form one molecule of cystine (structure shown in Figure 3D ).
| Quantification of mtDNA
We observed no significant differences in mtDNA copy number between controls and patients, nor between the early-and late-onset bipolar patients (Figure 4 ). This indicates that, despite the increase in oxidative stress seen in patients with bipolar disorder, it was not paralleled by an increase in mtDNA in this cohort.
TA In healthy volunteers, a positive correlation was observed between BMI and the Cyss/Cys redox state (Supporting Information Figure S1A ), but no correlation was observed in either of the patient groups ( Figures S1B and S1C ).
| Patients treated with and without lamotrigine showed no significant differences in oxidative stress
No significant differences were observed in the plasma glutathione redox state between those patients on lamotrigine and those not on the drug using an unpaired t test ( Figure S2 ).
| D ISCUSS I ON
Our results again demonstrate that there is a significant increase in oxidative stress in bipolar patients, compared to matched controls. 1, 17, 18 In this study, the difference was driven by an increase in oxidized glutathione, rather than a reduction in reduced glutathione.
The change in redox potential of glutathione was the same as described in our previous study. In contrast, we did not replicate our earlier finding of a relationship between oxidative stress and age of illness onset. There was no evidence for a change in the redox potential of cysteine or evidence of change in the quantity of mtDNA in the patient groups, compared with controls.
Oxidative stress is purported to play a pathological role in the development and neuroprogression of diseases such as schizophrenia and bipolar disorder. 19 However, its accurate measurement is far 
F I G U R E 4
Scatterplots showing the relative amount of mtDNA on the y-axis, for healthy controls (black) and early-onset (blue) and late-onset (red) bipolar patients. Data were analysed using a oneway ANOVA and no significant differences were observed [Colour figure can be viewed at wileyonlinelibrary.com] cystine form a plasma pool that is approximately 25 times larger than the glutathione pool in healthy people and so must be separated from it. 3, 20 To obtain the most accurate measure of the oxidative state of the body accordingly requires a specific and accurate assay;
HPLC, as employed here, is state of the art.
We divided the patient groups into early and late onset, matching for age. However, no differences were observed in any of the measures between the two groups. Thus, we have shown no replicated correlations between clinical measures and oxidative stress in either study. The absence of correlations with current mood (data not shown) is also notable. All patients were euthymic and on medication at the time of the study, so it is feasible that glutathione-related oxidative stress might yet be a "state"-related biomarker. We have simply not made measurements during acute mania or depression. Similar considerations may apply to the absence of an effect on mtDNA; other studies have suggested that the changes in mtDNA were partially reversible, and reflective of a stressful environment or childhood abuse. 8 Moreover, it is as yet unclear how this measure might relate to bipolar disorder, as some studies have found changes 12,21 whereas others have not.
22
Mitochondria are certainly more sensitive to an oxidizing environment (compared to other organelles) as they exist in the most reducing state compared to other organelles 23 and lack protective histones, 21 but these subtleties may not be captured by the mtDNA measure employed here.
Curiously, the BMI showed a positive correlation with cystine/ cysteine redox state, as expected, in healthy controls, 24 but not in patients. These data ( Figure S1 ) suggest that there is a disruption of "normal" metabolic processes in bipolar patients and this may be related to patient medication or disease itself, and warrants more rigorous testing in a future study. Additionally, although some have suggested that lamotrigine's therapeutic effects might relate to its antioxidant capabilities, 25 we did not find any differences in oxidative stress in patients treated with lamotrigine, vs those who were not ( Figure S2 ). One caveat, though, is that the group numbers were slightly skewed as the latter group had 20 additional patients.
The absence of a group difference in total glutathione is relevant to studies that have used magnetic resonance spectroscopy to measure changes in brain glutathione. 26 Spectroscopy measures only total glutathione in the target tissue of interest; our findings here show that changes in total glutathione do not necessarily reflect changes in oxidative state. Small changes in oxidized glutathione, not assessable by spectroscopy, are far better predictors of oxidative stress. Moreover, the redox state of a cell and tissue is directly related to the plasma concentrations of oxidized and reduced glutathione. Essentially, all organs communicate with one another regarding their oxidative status through the blood thiol redox state. Therefore, plasma glutathione redox is a better indicator of brain oxidative stress than total brain glutathione. We suggest that combining a plasma measure of glutathione along with brain spectroscopy might add sensitivity.
Some limitations of the study include a modest sample size, and the heterogeneous nature of the bipolar illness course, which is difficult to measure with accepted metrics. We included both bipolar I and II patients because the distinction between them is arbitrary (reflecting the severity of the manic pole of the illness) and in euthymia we see no clinical differences between the two. 27 Indeed, we observed no significant difference in glutathione redox state between bipolar I and II patient groups ( Figure S3 ).
In conclusion, we show that oxidative stress is increased in bipolar disorder, even when patients are euthymic. Future research should establish a unified methodology of measuring and defining oxidative stress so that the data are comparable. Additionally, it might be informative to assess these measures when patients are in extreme mood states, or have not yet been prescribed medication, to ascertain how oxidative stress might be a biomarker of disease prognosis.
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